Choroidal involution is a key component of oxygen-induced retinopathy.
暂无分享,去创建一个
Pierre Lachapelle | Swathi Seshadri | Przemyslaw Sapieha | J. Mancini | P. Hardy | S. Chemtob | F. Sennlaub | Florian Sennlaub | P. Sapieha | Jean-Sébastien Joyal | P. Lachapelle | D. Varma | E. Kermorvant-Duchemin | Zhuo Shao | Allison L Dorfman | Mikheil Djavari | Elsa Kermorvant-Duchemin | Martine Blais | Anna Polosa | Daya R Varma | Jean-Sébastien Joyal | Pierre Hardy | Nicholas Sitaras | Emilie Picard | Joseph Mancini | Sylvain Chemtob | É. Picard | N. Sitaras | Z. Shao | A. Dorfman | Martine Blais | Anna Polosa | Swathi Seshadri | M. Djavari | Nicholas Sitaras
[1] W. Tasman,et al. Cryotherapy for retinopathy of prematurity: a histopathologic comparison of a treated and untreated eye. , 1994, Ophthalmic surgery.
[2] P. Hardy,et al. Inflammatory lipid mediators in ischemic retinopathy. , 2005, Pharmacological reports : PR.
[3] J. Morrow,et al. The cyclopentenone (A2/J2) isoprostanes--unique, highly reactive products of arachidonate peroxidation. , 2005, Antioxidants & redox signaling.
[4] J. Penn,et al. The development of the rat model of retinopathy of prematurity , 2010, Documenta Ophthalmologica.
[5] Gary W. Williams,et al. Ocular hypotensive DP-class prostaglandin receptor affinities determined by quantitative autoradiography on human eye sections. , 2005, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.
[6] F. Cañada,et al. Modification of Proteins by Cyclopentenone Prostaglandins is Differentially Modulated by GSH in Vitro , 2007, Annals of the New York Academy of Sciences.
[7] S. Chemtob,et al. Graded contribution of retinal maturation to the development of oxygen-induced retinopathy in rats. , 2001, Investigative ophthalmology & visual science.
[8] S. Molotchnikoff,et al. Regulation of endothelial nitric oxide synthase by PGD(2) in the developing choroid. , 2000, American journal of physiology. Heart and circulatory physiology.
[9] J. Morrow,et al. Cyclopentenone Eicosanoids as Mediators of Neurodegeneration: A Pathogenic Mechanism of Oxidative Stress‐Mediated and Cyclooxygenase‐Mediated Neurotoxicity , 2005, Brain pathology.
[10] R. Hansen,et al. Multifocal ERG in Subjects with a History of Retinopathy of Prematurity , 2005, Documenta Ophthalmologica.
[11] Xiaoling Liang,et al. [Quantification of oxygen-induced retinopathy in the mouse]. , 2006, Yan ke xue bao = Eye science.
[12] H. Forman,et al. Biphasic Effects of 15-Deoxy-&Dgr;12,14-Prostaglandin J2 on Glutathione Induction and Apoptosis in Human Endothelial Cells , 2001, Arteriosclerosis, thrombosis, and vascular biology.
[13] J. Morrow,et al. Interaction of electrophilic lipid oxidation products with mitochondria in endothelial cells and formation of reactive oxygen species. , 2006, American journal of physiology. Heart and circulatory physiology.
[14] D. S. Mcleod,et al. Vaso-obliteration in the canine model of oxygen-induced retinopathy. , 1996, Investigative ophthalmology & visual science.
[15] R. A. Petersen,et al. The rod photoreceptors in retinopathy of prematurity: an electroretinographic study. , 2001, Archives of ophthalmology.
[16] C. Gilbert,et al. Childhood blindness in the context of VISION 2020--the right to sight. , 2001, Bulletin of the World Health Organization.
[17] S. Chemtob,et al. Immunohistochemical evidence of synaptic retraction, cytoarchitectural remodeling, and cell death in the inner retina of the rat model of oygen-induced retinopathy (OIR). , 2011, Investigative ophthalmology & visual science.
[18] Youngchul Kim,et al. 15-Deoxy-delta12,14-prostaglandin J2, a neuroprotectant or a neurotoxicant? , 2005, Toxicology.
[19] F. Recchia,et al. FOVEAL DYSPLASIA EVIDENT BY OPTICAL COHERENCE TOMOGRAPHY IN PATIENTS WITH A HISTORY OF RETINOPATHY OF PREMATURITY , 2007, Retina.
[20] M. Hartnett,et al. Neutralizing antibody to VEGF reduces intravitreous neovascularization and may not interfere with ongoing intraretinal vascularization in a rat model of retinopathy of prematurity , 2008, Molecular vision.
[21] Y. Courtois,et al. Cyclooxygenase-2 in Human and Experimental Ischemic Proliferative Retinopathy , 2003, Circulation.
[22] Lois E. H. Smith,et al. High or Low Oxygen Saturation and Severe Retinopathy of Prematurity: A Meta-analysis , 2010, Pediatrics.
[23] I. Abramov,et al. Color vision measured with pseudoisochromatic plates at five-and-a-half years in eyes of children from the CRYO-ROP study. , 1996, Investigative ophthalmology & visual science.
[24] Thomas Krucker,et al. New polyurethane‐based material for vascular corrosion casting with improved physical and imaging characteristics , 2006, Microscopy research and technique.
[25] T. Osawa,et al. Cyclopentenone Prostaglandins as Potential Inducers of Intracellular Oxidative Stress* , 2001, The Journal of Biological Chemistry.
[26] J. Morrow,et al. Formation of Reactive Cyclopentenone Compounds in Vivo as Products of the Isoprostane Pathway* , 1999, The Journal of Biological Chemistry.
[27] Y. Fei,et al. Development of the cone photoreceptor mosaic in the mouse retina revealed by fluorescent cones in transgenic mice. , 2003, Molecular vision.
[28] J. Lehmann,et al. A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor γ and promotes adipocyte differentiation , 1995, Cell.
[29] James D. Akula,et al. The neurovascular retina in retinopathy of prematurity , 2009, Progress in Retinal and Eye Research.
[30] J. Rivera,et al. Proliferative retinopathies: angiogenesis that blinds. , 2010, The international journal of biochemistry & cell biology.
[31] P. Overbeek,et al. Regulation of choroid development by the retinal pigment epithelium. , 2001, Molecular vision.
[32] O. Dammann,et al. Retinopathy of prematurity , 2013, The Lancet.
[33] S. Cringle,et al. Intraretinal oxygen distribution in the rat with graded systemic hyperoxia and hypercapnia. , 1999, Investigative ophthalmology & visual science.
[34] A. Landar,et al. Accumulation of 15-deoxy-delta(12,14)-prostaglandin J2 adduct formation with Keap1 over time: effects on potency for intracellular antioxidant defence induction. , 2008, The Biochemical journal.
[35] Leopold Schmetterer,et al. Ocular blood flow in diabetes and age-related macular degeneration. , 2008, Canadian journal of ophthalmology. Journal canadien d'ophtalmologie.
[36] P. Hardy,et al. Hyperoxic Exposure Leads to Nitrative Stress and Ensuing Microvascular Degeneration and Diminished Brain Mass and Function in the Immature Subject , 2006, Stroke.
[37] W. Erl,et al. Cyclopentenone prostaglandins induce endothelial cell apoptosis independent of the peroxisome proliferator‐activated receptor‐γ , 2004, European journal of immunology.
[38] M. Gerritsen,et al. Peroxisome Proliferator-activated Receptor γ Ligands Are Potent Inhibitors of Angiogenesis in Vitro and in Vivo * , 1999, The Journal of Biological Chemistry.
[39] S. Chemtob,et al. Early manifestations of postnatal hyperoxia on the retinal structure and function of the neonatal rat. , 2008, Investigative ophthalmology & visual science.
[40] M. Hartnett,et al. VEGF isoforms and their expression after a single episode of hypoxia or repeated fluctuations between hyperoxia and hypoxia: relevance to clinical ROP. , 2004, Molecular vision.
[41] S. Joly,et al. Functional and structural changes resulting from strain differences in the rat model of oxygen-induced retinopathy. , 2009, Investigative ophthalmology & visual science.
[42] E. Niki. Lipid peroxidation: physiological levels and dual biological effects. , 2009, Free radical biology & medicine.
[43] J. Kiel,et al. ROP surgery and ocular circulation , 2008, Eye.
[44] N. Sharif,et al. Pharmacology and autoradiography of human DP prostanoid receptors using [3H]‐BWA868C, a DP receptor‐selective antagonist radioligand , 2000, British journal of pharmacology.
[45] Magali Saint-Geniez,et al. Development and pathology of the hyaloid, choroidal and retinal vasculature. , 2004, The International journal of developmental biology.
[46] J. Penn,et al. Exposure to Alternating Hypoxia and Hyperoxia Causes Severe Proliferative Retinopathy in the Newborn Rat , 1994, Pediatric Research.
[47] T. Matsuura,et al. Diabetic retinopathy and choroidal angiopathy in diabetic rats (WBN/Kob). , 2009, Experimental animals.
[48] Lynn Marran,et al. Moving the retina: Choroidal modulation of refractive state , 1995, Vision Research.
[49] J. Joseph,et al. Doxorubicin-induced Apoptosis in Endothelial Cells and Cardiomyocytes Is Ameliorated by Nitrone Spin Traps and Ebselen , 2000, The Journal of Biological Chemistry.
[50] Demetrios Vavvas,et al. Review of the Ocular Angiogenesis Animal Models , 2009, Seminars in ophthalmology.
[51] W. Tasman,et al. Optical coherence tomography imaging of the fovea in retinopathy of prematurity. , 2010, Ophthalmic surgery, lasers & imaging : the official journal of the International Society for Imaging in the Eye.
[52] D. Flaherty,et al. Dihydrofluorescein diacetate is superior for detecting intracellular oxidants: comparison with 2',7'-dichlorodihydrofluorescein diacetate, 5(and 6)-carboxy-2',7'-dichlorodihydrofluorescein diacetate, and dihydrorhodamine 123. , 1999, Free radical biology & medicine.
[53] B. Berkowitz,et al. Abnormal panretinal response pattern to carbogen inhalation in experimental retinopathy of prematurity. , 1998, Investigative ophthalmology & visual science.
[54] D. Gilroy,et al. Inducible cyclooxygenase may have anti-inflammatory properties , 1999, Nature Medicine.
[55] Tzong-Shyuan Lee,et al. Induction of Heme Oxygenase-1 Expression in Murine Macrophages Is Essential for the Anti-inflammatory Effect of Low Dose 15-Deoxy-Δ12,14-prostaglandin J2* , 2003, Journal of Biological Chemistry.
[56] A. Madan,et al. Animal models of oxygen-induced retinopathy. , 2003, Frontiers in bioscience : a journal and virtual library.
[57] P. Hardy,et al. Oxidants, nitric oxide and prostanoids in the developing ocular vasculature: a basis for ischemic retinopathy. , 2000, Cardiovascular research.
[58] P. Hardy,et al. Nitric Oxide in Retinal and Choroidal Blood Flow Autoregulation in Newborn Pigs: Interactions with Prostaglandins , 1996, Pediatric Research.
[59] O. Ates,et al. Oxidative DNA Damage in Retinopathy of Prematurity , 2009, European journal of ophthalmology.
[60] J. Pfitzner,et al. Poiseuille and his law , 1976, Anaesthesia.
[61] R. Higgins,et al. Ibuprofen improves oxygen-induced retinopathy in a mouse model , 2003, Current eye research.
[62] P. Hardy,et al. Increased nitric oxide synthesis and action preclude choroidal vasoconstriction to hyperoxia in newborn pigs. , 1996, Circulation research.
[63] J. Szlyk,et al. MACULAR STRUCTURE AND VISION OF PATIENTS WITH MACULAR HETEROTOPIA SECONDARY TO RETINOPATHY OF PREMATURITY , 2008, Retina.
[64] E. Palmer,et al. Severe visual impairment in children with mild or moderate retinal residua following regressed threshold retinopathy of prematurity. , 2007, Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus.
[65] P. Hardy,et al. Understanding ischemic retinopathies: emerging concepts from oxygen-induced retinopathy , 2010, Documenta Ophthalmologica.
[66] P. Hardy,et al. Redox-dependent effects of nitric oxide on microvascular integrity in oxygen-induced retinopathy. , 2004, Free radical biology & medicine.
[67] G. Almazan,et al. Role of thromboxane in retinal microvascular degeneration in oxygen-induced retinopathy. , 2001, Journal of applied physiology.
[68] R. Hansen,et al. Photoreceptor function in infants and children with a history of mild retinopathy of prematurity. , 1996, Journal of the Optical Society of America. A, Optics, image science, and vision.
[69] D. S. Mcleod,et al. Quantifying changes in RPE and choroidal vasculature in eyes with age-related macular degeneration. , 2002, Investigative ophthalmology & visual science.
[70] A. Adamis,et al. Sensitive blood-retinal barrier breakdown quantitation using Evans blue. , 2001, Investigative ophthalmology & visual science.
[71] S. Chemtob,et al. Postnatal hyperoxia and the developing rat retina: beyond the obvious vasculopathy , 2010, Documenta Ophthalmologica.
[72] F. Bowen,et al. Severe retinopathy of prematurity in infants with birth weights less than 1250 grams: incidence and outcome of treatment with pharmacologic serum levels of vitamin E in addition to cryotherapy from 1985 to 1991. , 1995, The Journal of pediatrics.
[73] R. A. Petersen,et al. Dark-adapted thresholds in children with histories of mild retinopathy of prematurity. , 1997, Investigative ophthalmology & visual science.
[74] R. Hansen,et al. Development of Rod Function in Term Born and Former Preterm Subjects , 2009, Optometry and vision science : official publication of the American Academy of Optometry.
[75] C. Distler,et al. Müller cells in vascular and avascular retinae: A survey of seven mammals , 1992, The Journal of comparative neurology.
[76] G. Lutty,et al. Choriocapillaris degeneration and related pathologic changes in human diabetic eyes. , 1998, Archives of ophthalmology.